Marron Bio Innovations Inc. (MBII)
Our attorneys are investigating customer losses in Marron Bio Innovations., an investment offered and sold by National Securities Corporation Inc. (NSC) to its retail clients.
If you have suffered losses in Marron Bio Innovations Inc., please contact our lawyers for a free and confidential consultation concerning your legal rights and the possibility of recovery.
At Silver Law Group, we know from experience that not every investment recommended and solicited by a stockbroker is suitable and appropriate for the customer. We have seen, particularly in the initial public offering (IPO) space, that investors are often falsely promised high returns and low risk, when in truth the investment is speculative and subject to the loss of principal. Your financial advisor and the securities firm who sells the investment have a legal duty to fully explain the nature of the investment, its inherent risks and the possibility of loss.
Brokers and financial advisors may push risky initial public offerings on unsuspecting investors based upon strong financial incentives, including large commission payouts. Investors in such offerings must realize that these investments are inherently risky and should be considered very carefully before making a decision to invest. Representations made by stockbrokers that such investments are “safe” and “guaranteed” are typically false and are a red flag of possible fraud.National Securities Corporation Inc. Role in the Investment:
In April of 2017, National Securities Corporation underwrote Marron Bio Innovations Inc.’s common stock offering. At the close of the offering, National Securities Corporation raised over 9 million ($9,200,000.00). Marron Bio Innovations Inc. was listed on the Nasdaq under the stock symbol “MBII”. As of November 13, 2017, Marron Bio Innovations Inc stock is worth $0.94 per share.Marron Bio Innovations Inc. Company Profile:
Marron Bio Innovations Inc. describes themselves as experts at discovering, developing, and commercializing naturally derived technologies, we have created an industry-leading platform of pest management and plant health products that are used in agricultural, turf and ornamental, and water treatment applications. Their website describes solutions that help customers around the globe control pests, improve plant health, and increase crop yields while reducing the environmental pesticide load, decreasing chemical residues on food, and fighting the development of pest resistance.
Dr. Pamela Marrone, CEO and founder of Marrone Bio Innovations (MBI), started the company in 2006 to discover and develop effective and environmentally-responsible, biologically-based products for pest management and plant health. In August 2013, she led the company to be listed on the NASDAQ stock exchange, raising net proceeds of $56.4 million.
Silver Law Group represents investment fraud victims in cases to recover their investment losses. If you have questions about your legal rights, please contact Scott Silver of the Silver Law Group for a free consultation at email@example.com or toll-free at (800) 975-4345.